{"organizations": [], "uuid": "1b3518c20d88f3bf7811aae35bc375c3dad4187c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pacific-biosciences-prevails-in-pa/brief-pacific-biosciences-prevails-in-patent-eligibility-ruling-idUSFWN1R4125", "country": "US", "domain_rank": 408, "title": "BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T23:04:00.000+02:00", "replies_count": 0, "uuid": "1b3518c20d88f3bf7811aae35bc375c3dad4187c"}, "author": "", "url": "https://www.reuters.com/article/brief-pacific-biosciences-prevails-in-pa/brief-pacific-biosciences-prevails-in-patent-eligibility-ruling-idUSFWN1R4125", "ord_in_thread": 0, "title": "BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling", "locations": [], "entities": {"persons": [{"name": "eligi", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "pacific", "sentiment": "none"}], "organizations": [{"name": "brief-pacific biosciences", "sentiment": "negative"}, {"name": "oxford nanopore", "sentiment": "none"}, {"name": "ruling reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "biosciences", "sentiment": "none"}, {"name": "pacific biosciences of california inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 9:05 PM / Updated 11 minutes ago BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling Reuters Staff March 22 (Reuters) - Pacific Biosciences Of California Inc : * PACIFIC BIOSCIENCES PREVAILS IN PATENT ELIGIBILITY RULING AGAINST OXFORD NANOPORE * PACIFIC BIOSCIENCES - U.S. DISTRICT COURT DENIED A MOTION TO DISMISS FILED ON DEC 14, 2017 BY UNIT OF OXFORD NANOPORE TECHNOLOGIES LTDâ€‹ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-22T23:04:00.000+02:00", "crawled": "2018-03-22T23:28:01.003+02:00", "highlightTitle": ""}